News

SANTIAGO, October 15, 2001 (LSN.ca) – Chilean Health Minister Michelle Bachelet announced Thursday that health care officials will distribute the abortifacient morning after pill, Postinor-2, free of charge. The decision comes as a surprise since Chile’s Supreme Court banned a similar morning after pill on August 30. However, the ruling reflects an appeals court ruling Wednesday which permitted the new pill.

The same day that the Supreme Court in Chile banned the morning after pill -Postinal – since it can cause an abortion, the Ministry of Health approved Postinor-2 arguing that the court only banned a certain brand-name of abortifacient morning-after pill. Pro-lifers appealed to the Santiago Appeals Court to issue a clarification indicating that the ban was placed on the Postinal since it is abortifacient and thus was counter to Chile’s pro-life legislation. However, the Appeals Court ruled Wednesday that Postinor-2 is allowable.

Dan Zeidler, President of the Family Life Council and a representative for the Latin American Alliance for the Family, told LifeSite that the Appeals Court decision will be appealed to the Supreme Court.

The socialist Chilean government is also considering legalizing divorce.

See related coverage:  https://library.northernlight.com/FD20011011730000080.html?cb=0&dx=1006&sc=0#doc https://dailynews.yahoo.com/h/ap/20011014/wl/divorce_chilean_style_1.html

Comments

Commenting Guidelines
LifeSiteNews welcomes thoughtful, respectful comments that add useful information or insights. Demeaning, hostile or propagandistic comments, and streams not related to the storyline, will be removed.

LSN commenting is not for frequent personal blogging, on-going debates or theological or other disputes between commenters.

Multiple comments from one person under a story are discouraged (suggested maximum of three). Capitalized sentences or comments will be removed (Internet shouting).

LifeSiteNews gives priority to pro-life, pro-family commenters and reserves the right to edit or remove comments.

Comments under LifeSiteNews stories do not necessarily represent the views of LifeSiteNews.

0 Comments

    Loading...